PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Clinical trials for PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA trials appear
Sign up with your email to follow new studies for PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to shrink brain tumors in lymphoma patients
Disease control Not yet recruitingThis study tests whether adding the targeted drug orelabrutinib to standard chemotherapy can improve outcomes for people newly diagnosed with primary central nervous system lymphoma (PCNSL), a rare brain cancer. About 215 adults will be randomly assigned to one of three treatment…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated May 26, 2026 05:28 UTC
-
New model aims to predict kidney risk from chemo in brain cancer
Knowledge-focused Not yet recruitingThis study looks at 50 adults with primary central nervous system lymphoma who are receiving high-dose methotrexate, a key chemotherapy. The goal is to use early blood tests to predict which patients are at risk for kidney damage, which can be life-threatening. Researchers will t…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated May 26, 2026 05:35 UTC